An inverse correlation between WT1 and MYCN expressions is revealed in neuroblastoma (NB).
High expression of WT1 is associated with lower survival in non-MYCN-amplified NB.
Flat and substrate-adherent NB cells express high levels of WT1.
WT1 is potentially a prognostic marker in NB without MYCN amplification.